Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infant Formula Price-Fixing Suit Jurisdiction Granted High Court Review

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Supreme Court on Nov. 29 agreed to decide whether a Louisiana state court lawsuit alleging infant formula price-fixing was properly removed to federal court, where it was eventually dismissed. The high court's decision in Free v. Abbott Laboratories is expected by July.

You may also be interested in...



Federal Jurisdiction Of Formula Price-Fixing Suit Appropriate - Companies

The claims of absent class members in an infant formula price-fixing lawsuit are part of the same "case or controversy" as the named plaintiffs' claims over which a Louisiana federal court had jurisdiction to dismiss, Abbott Labs and Bristol-Myers Squibb tell the U.S. Supreme Court.

Federal Jurisdiction Of Formula Price-Fixing Suit Appropriate - Companies

The claims of absent class members in an infant formula price-fixing lawsuit are part of the same "case or controversy" as the named plaintiffs' claims over which a Louisiana federal court had jurisdiction to dismiss, Abbott Labs and Bristol-Myers Squibb tell the U.S. Supreme Court.

Federal Jurisdiction Of Formula Price-Fixing Suit Appropriate - Companies

The claims of absent class members in an infant formula price-fixing lawsuit are part of the same "case or controversy" as the named plaintiffs' claims over which a Louisiana federal court had jurisdiction to dismiss, Abbott Labs and Bristol-Myers Squibb tell the U.S. Supreme Court.

Topics

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel